10 Pharma Companies Making Treatment for Opioid Overdose
In this article, we discuss the 10 pharma companies making treatment for opioid overdose.
Opiant Pharmaceuticals Inc. (OPNT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fifth Lane Capital Cavan Copeland | 0 | $0 | 0% | |
| 2. | Schonfeld Strategic Advisors Ryan Tolkin (Cio) | 0 | $0 | 0% | |
| 3. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% | |
| 4. | Two Sigma Advisors John Overdeck And David Siegel | 0 | $0 | 0% | |
| 5. | GAMCO Investors Mario Gabelli | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.94 | 4,037 | $44,148.63 | 53,822 | 2022-06-13 | Filing | |
| $11.50 | 1,663 | $19,117.85 | 49,785 | 2022-06-10 | Filing | |
| $13.29 | 2,500 | $33,220.00 | 21,343 | 2022-05-16 | Filing | |
| $13.54 | 27,150 | $367,611.00 | 48,122 | 2022-05-16 | Filing | |
| $10.49 | 3,689 | $38,697.61 | 20,972 | 2022-05-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.26 | 1,358 | $27,513.08 | 75,339 | 2023-01-27 | Filing | |
| $20.26 | 610 | $12,358.60 | 18,751 | 2023-01-27 | Filing | |
| $20.26 | 444 | $8,995.44 | 31,990 | 2023-01-27 | Filing | |
| $20.26 | 480 | $9,724.80 | 21,548 | 2023-01-27 | Filing | |
| $20.26 | 541 | $10,960.66 | 34,248 | 2023-01-27 | Filing |
Institutional Investors' Holdings
News See All
Where Do Hedge Funds Stand On Opiant Pharmaceuticals, Inc. (OPNT)?
In this article we will check out the progression of hedge fund sentiment towards Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) and determine whether it is a good investment right now.
Hedge Funds Getting Bullish On Opiant Pharmaceuticals, Inc. (OPNT)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Opiant Pharmaceuticals, Inc. (OPNT): Hedge Funds Watching From Afar
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Riverbed Technology, Inc. (RVBD), Palo Alto Networks Inc (PANW), Aruba Networks, Inc. (ARUN): How Will 2013 Bode for These 3 Tech Companies?
With Forrester anticipating a smoother ride ahead for the US tech industry, it will be interesting to see how CIOs invest their IT budgets.
Billionaire Hedge Funds
